Perrine Roux, Pharm.D., Ph.D., French National Institute of Health and Medical Research (Inserm), has been selected as a NIDA INVEST Drug Abuse Research Fellow. She will work with Sandra D. Comer, Ph.D., Columbia University, to better define the concept of nonadherence to opioid maintenance treatment with buprenorphine/naloxone and to validate a tool to measure nonadherence using a self-administered questionnaire.
NIDA and the French Institut national de la santé et de la recherche médicale (INSERM) co-hosted a workshop during the Society for Neuroscience annual conference to explore opportunities to enhance collaborative research and research training activities between the United States and France. NIDA Director Nora Volkow, M.D., and Etienne Hirsch, Ph.D., INSERM, co-chaired the October 15, 2012, workshop. After speakers described the research priorities and capabilities of the two organizations, the invited U.S.
Signing the binational agreement between NIDA and Institut National de la Santé et de la Recherche Médicale (Inserm) are, from left, NIDA Director Nora D. Volkow, M.D.; His Excellency François Delattre, Ambassador of France; and Inserm Chair and Chief Executive Officer André Syrota, M.D.